ÂÜÀòÂÒÂ×

After serving in the Swedish Royal Navy, Mr. Schüberg received a degree in Business Administration from the London Guildhall University in the United Kingdom. He began his career with the Danish pharmaceutical company H. Lundbeck A/S in 1994, serving in different commercial positions in South Africa and Sweden.

After three years with the company, he worked briefly as an International Marketing Manager for respiratory therapies at Astra Draco AB in Sweden, before returning to Lundbeck as an International Marketing Director for the company's global psychiatry business unit. During this time, he helped launch key company products in both Europe and the United States. Subsequently, he launched and managed the company's business in Portugal and, in 2005, assumed the position of Regional Vice President for southern Europe, before taking on all the major markets in Europe. In 2010, he was appointed President and Chairman of Lundbeck's U.S. operation. The U.S. business more than tripled in size during his tenure. From 2016 to 2018, he served as Global Chief Commercial Officer and member of the Executive team of the Lundbeck group.

In 2018, he was appointed CEO and Board member of the ESTEVE Group. He is a member of the Board of Directors of Dizlin Pharmaceuticals AB, Sobi and The European Federation of Pharmaceutical Industries and Associations (EFPIA).